About the job
Axsome Therapeutics is at the forefront of biopharmaceutical innovation, spearheading a transformative approach to the treatment of central nervous system (CNS) disorders. Our commitment to addressing significant gaps in patient care drives us to develop unique products that leverage novel mechanisms of action, leading to substantial improvements in patient outcomes. Our distinguished neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, and migraines, alongside multiple late-stage development programs targeting a wide array of serious neurological and psychiatric conditions that affect over 150 million individuals in the United States. Together, we are dedicated to tackling some of the most pressing challenges in brain health, empowering patients and their families to thrive. Explore more about us at www.axsome.com
